Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis measured with disease and symptom specific questionnaires.

Trial Profile

Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis measured with disease and symptom specific questionnaires.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jan 2017

At a glance

  • Drugs Nintedanib (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top